Analysis of CAR-Mediated Tonic Signaling
Authors:
- 10 November 2019
- book chapter
- Published by Springer Nature
- Vol. 2086, 223-236
Abstract
CARs are synthetic receptors designed to drive antigen-specific activation upon binding of the scFv to its cognate antigen. However, CARs can also elicit different levels of ligand-independent constitutive signaling, also known as tonic signaling. Chronic T cell activation is observed in certain combinations of scFv, hinge, and costimulatory domains and may be increased due to high levels of CAR expression. Tonic signaling can be identified during primary T cell expansion due to differences in the phenotype and growth of CAR-T cells compared to control T cells. CARs displaying tonic signaling are associated with accelerated T cell differentiation and exhaustion and impaired antitumor effects. Selecting CARs which configuration does not induce tonic signaling is important to enhance antigen-specific T cell responses. In this chapter, we describe in detail different protocols to identify tonic signaling driven by CARs during primary T cell ex vivo expansion.Keywords
This publication has 14 references indexed in Scilit:
- Emerging Cellular Therapies for CancerAnnual Review of Immunology, 2019
- Engineering and Design of Chimeric Antigen ReceptorsMolecular Therapy - Methods & Clinical Development, 2019
- Strategies to Address Chimeric Antigen Receptor Tonic SignalingMolecular Cancer Therapeutics, 2018
- Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell MalignanciesCancer Immunology Research, 2018
- Tonic 4-1BB Costimulation in Chimeric Antigen Receptors Impedes T Cell Survival and Is Vector-DependentCell Reports, 2017
- Molecular and cellular insights into T cell exhaustionNature Reviews Immunology, 2015
- 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptorsNature Medicine, 2015
- Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T CellsCancer Immunology Research, 2015
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid TumorsClinical Cancer Research, 2014
- Tolerance and exhaustion: defining mechanisms of T cell dysfunctionTrends in Immunology, 2014